Zantac Lawsuit Payouts and Settlement Costs Cause Concerns Among Drug Company Investors
Approaching trial dates and analyst estimates that Zantac settlement payouts may reach $45 billion caused investor stock selloff this week
Approaching trial dates and analyst estimates that Zantac settlement payouts may reach $45 billion caused investor stock selloff this week
The cancer-causing contaminant, a nitrosamine, was detected at levels exceeding the daily acceptable allowance set by the FDA, but there will be no recall due to fears of a shortage.
Court has pushed back the start of first California Zantac trials, with cases set to go before juries starting in February, May, August and October 2023
Motions were filed in advance of hearings scheduled for September 2022, at which time the Court will weigh the reliability of expert testimony on the link between Zantac and cancer.
MDL Judge will decide at a series of Daubert hearings which expert testimony about the link between Zantac and cancer will be admissible at trial
Patients with recalled Accuretic pills are being told to continue taking the drug until advised otherwise by a healthcare provider.
Reports suggest more than 100,000 claims have been registered in the Zantac MDL, alleging various cancers were caused by the recalled heartburn pills
Thousands of lawsuits are being pursued by individuals alleging that recalled Zantac caused cancer. However, MDL expert testimony will only support that the heartburn drug may have caused five specific types of cancer.
NDMA contamination has resulted in several major drug recalls in recent years, including Zantac and valsartan.
The non-adversarial presentations involving the science behind the heartburn drug's cancer risks will be held today and tomorrow in southern Florida.